2023 | | Biomarkers for predicting type 2-high and uncontrolled asthma in real-world practice | 김승현, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2021 | | Biomarkers for severe Asthma: Lessons from longitudinal cohort studies | 박해심, 이영수 |
2021 | | Cefaclor-induced hypersensitivity: Differences in the incidence of anaphylaxis relative to other 2nd and 3rd generation cephalosporins | 예영민, 이영수, 장재혁 |
2021 | | Changes in type 2 biomarkers after anti-il5 treatment in patients with severe eosinophilic asthma | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2024 | | Characteristics of Severe Asthma in the Elderly: Observations From the Korean Severe Asthma Registry (KoSAR) | 이영수 |
2021 | | Characteristics of Specialist-Diagnosed Asthma-COPD Overlap in Severe Asthma: Observations from the Korean Severe Asthma Registry (KoSAR) | 박해심, 이영수 |
2019 | | Chlorpheniramine-induced anaphylaxis: Two case reports and a retrospective review of pharmacovigilance database | 예영민, 우성대, 이소희, 이영수 |
2021 | | Clinical characteristics and risk factors for cefaclor-induced immediate hypersensitivity: a retrospective observation at two university hospitals in Korea | 예영민, 우성대, 이영수 |
2021 | | Clustering the clinical course of chronic urticaria using a longitudinal database: Effects on urticaria remission | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2020 | | Common causes and characteristics of adverse drug reactions in older adults: a retrospective study | 예영민, 우성대, 이영수 |
2022 | | Content-based Image Retrieval by Using Deep Learning for Interstitial Lung Disease Diagnosis with Chest CT | 이영수 |
2022 | | Detection of serum IgG autoantibodies to FcεRIα by ELISA in patients with chronic spontaneous urticaria | 박해심, 예영민, 유민숙, 이영수, 장재혁 |
2024 | | Diagnostic biomarkers for chronic rhinosinusitis in adult asthmatics in real-world practice | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2022 | | Effectiveness of Maintenance and Reliever Therapy Using Inhaled Corticosteroid–Formoterol in Asthmatics | 박래웅, 박해심, 이영수, 장재혁 |
2020 | | Efficacy and Safety of a Pressurized Metered-Dose Inhaler in Older Asthmatics: Comparison to a Dry Powder Inhaler in a 12-Week Randomized Trial | 박주헌, 박해심, 신유섭, 예영민, 우성대, 이영수 |
2021 | | Erratum: Clustering the clinical course of chronic urticaria using a longitudinal database: Effects on urticaria remission | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2021 | | Establishment of reference intervals of serum immunoglobulins in healthy korean adults | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2020 | | Evaluation and Management of Difficult-to-Treat and Severe Asthma: An Expert Opinion From the Korean Academy of Asthma, Allergy and Clinical Immunology, the Working Group on Severe Asthma | 이영수 |
2022 | | Increased serum free IgE levels in patients with chronic spontaneous urticaria (CSU) | 박해심, 예영민, 유민숙, 이영수, 장재혁 |
2023 | | KAAACI Guidelines for Allergen Immunotherapy | 남동호, 신유섭, 이영수 |
2023 | | Long-term clinical outcomes of aspirin-exacerbated respiratory disease: Real-world data from an adult asthma cohort | 박래웅, 박해심, 이영수 |
2023 | | Long-term efficacy of anti-IL-4 receptor antibody in a patient with aspirin-exacerbated respiratory disease and IgG4-related disease | 박해심, 이영수, 장재혁, 전현섭 |
2021 | | Longitudinal Outcomes of Severe Asthma: Real-World Evidence of Multidimensional Analyses | 박래웅, 박해심, 이영수 |
2020 | | Management of Allergic Patients During the COVID-19 Pandemic in Asia | 박해심, 이영수 |
2019 | | Neutrophil activation in occupational asthma | 박해심, 이영수 |
2019 | | New phenotypes in hypersensitivity reactions to nonsteroidal anti-inflammatory drugs | 박해심, 신유섭, 이영수 |
2024 | | Predicting responses to omalizumab in antihistamine-refractory chronic urticaria: A real-world longitudinal study | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2021 | | Real clinical practice data of monthly dupilumab therapy in adult patients with moderate-to-severe atopic dermatitis: Clinical efficacy and predictive markers for a favorable clinical response | 남동호, 이영수 |
2024 | | Real-World Effectiveness of Statin Therapy in Adult Asthma | 박래웅, 박해심, 양형모, 이영수, 장재혁 |
2024 | | Real-world treatment trajectories of adults with newly diagnosed asthma or COPD | 박래웅, 박해심, 이영수 |
2024 | | Relationship of computed tomography-based measurements with symptom perception and quality of life in patients with severe asthma | 이영수 |
2023 | | Roles of real-world evidence in severe asthma treatment: challenges and opportunities | 이영수 |
2021 | | Serum-free immunoglobulin E: A useful biomarker of atopy and type 2 asthma in adults with asthma | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2021 | | Specialist perception of severe asthma in Korea: A questionnaire survey | 이영수 |
2024 | | The KAAACI Guidelines for Sublingual Immunotherapy | 남동호, 신유섭, 이영수 |
2023 | | Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study | 예영민, 이영수 |
2024 | | Work-related asthma in adults with severe asthma from the Korean Severe Asthma Registry (KoSAR) | 박해심, 이영수 |